Short intravenous amphotericin B followed by oral posaconazole using a simple, stratified treatment approach for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis: a prospective cohort study

被引:7
作者
Manesh, Abi [1 ]
Devasagayam, Emily [1 ]
Bhanuprasad, Kundakarla [1 ]
Varghese, Lalee [2 ]
Kurien, Regi [2 ]
Cherian, Lisa M. [2 ]
Dayanand, Divya [1 ]
George, Mithun M. [1 ]
Kumar, Selwyn S. [1 ]
Karthik, Rajiv [1 ]
Vanjare, Harshad [3 ]
Peter, Jayanthi [4 ]
Michael, Joy S. [5 ]
Thomas, Meera [6 ]
Mathew, Binu S. [7 ]
Samuel, Prasanna [8 ]
Peerawaranun, Pimnara [9 ]
Mukaka, Mavuto [9 ,10 ]
Rupa, Vedantam [2 ]
Varghese, George M. [1 ]
机构
[1] Christian Med Coll & Hosp, Dept Infect Dis, Vellore 632004, Tamil Nadu, India
[2] Christian Med Coll & Hosp, Dept ENT & Rhinol 3, Vellore, Tamil Nadu, India
[3] Christian Med Coll & Hosp, Dept Radiodiag, Vellore, Tamil Nadu, India
[4] Christian Med Coll & Hosp, Dept Ophthalmol, Vellore, Tamil Nadu, India
[5] Christian Med Coll & Hosp, Dept Clin Microbiol, Vellore, Tamil Nadu, India
[6] Christian Med Coll & Hosp, Dept Pathol, Vellore, Tamil Nadu, India
[7] Christian Med Coll & Hosp, Dept Clin Pharmacol, Vellore, Tamil Nadu, India
[8] Christian Med Coll & Hosp, Dept Biostat, Vellore, Tamil Nadu, India
[9] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok, Thailand
[10] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England
基金
英国惠康基金;
关键词
Diabetes -associated mucormycosis; Lipid emulsion amphotericin B; Oral posaconazole; Rhino-orbito-cerebral; Short intravenous amphotericin B; LIPID COMPLEX;
D O I
10.1016/j.cmi.2023.06.017
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To evaluate the efficacy and safety of short-course intravenous amphotericin B followed by sustained release posaconazole tablets for diabetes or COVID-19-associated rhino-orbito-cerebral mucormycosis.Methods: This prospective, pragmatic study included adults with diabetes or COVID-19-associated rhinoorbito-cerebral mucormycosis. Patients received short (7-14 days) or long (15-28 days) intravenous antifungal therapy (short intravenous antifungal treatment [SHIFT] or long intravenous antifungal treatment [LIFT], respectively) depending on the presence or absence of brain involvement. All patients received step-down posaconazole tablets, debridement, and glycemic control. The primary outcome was the treatment success at week 14, which was determined by assessing survival and the absence of disease progression through clinical evaluation and nasal endoscopy. Log-binomial regression analysis (risk ratio and 95% CI) was performed to assess factors associated with the primary outcome.Results: Intravenous therapy was administered to 251 participants: SHIFT, 205 (median duration, 13 days); LIFT, 46 (median duration, 22 days). Treatment success at 3 months was 88% (217/248; 95% CI, 83-91%): SHIFT group, 93% (189/203; 89-96%); LIFT group, 62% (28/45; 47-76%). All-cause mortality was 12% (30/251): SHIFT group, 6% (13/205); LIFT group, 37% (17/46). Age (aRR [95% CI]: 1.02 [1.00-1.05]; p 0.027), diabetic ketoacidosis at presentation (2.32 [1.20-4.46]; p 0.012), glycated haemoglobin A1c (1.19 [1.03-1.39]; p 0.019), stroke (3.93 [1.94-7.95]; p 0.0001), and brain involvement (5.67 [3.05 -10.54]; p < 0.0001) were independently associated with unsuccessful outcomes.Discussion: : Short intravenous amphotericin B with step-down posaconazole tablets should be further studied as primary treatment option for diabetes or COVID-19-associated mucormycosis in randomized
引用
收藏
页码:1298 / 1305
页数:8
相关论文
共 21 条
[1]   Risk factors associated with the mucormycosis epidemic during the COVID-19 pandemic [J].
Bhanuprasad, Kundakarla ;
Manesh, Abi ;
Devasagayam, Emily ;
Varghese, Lalee ;
Cherian, Lisa Mary ;
Kurien, Regi ;
Karthik, Rajiv ;
Deodhar, Divya ;
Vanjare, Harshad ;
Peter, Jayanthi ;
Michael, Joy S. ;
Thomas, Meera ;
Samuel, Prasanna ;
Varghese, George M. .
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 111 :267-270
[2]   COVID-19-Associated Rhino-Orbital-Cerebral Mucormycosis: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis [J].
Bhattacharyya, Anusuya ;
Sarma, Phulen ;
Kaur, Hardeep ;
Kumar, Subodh ;
Bhattacharyya, Jaimini ;
Prajapat, Manisha ;
Prakash, Ajay ;
Sharma, Saurabh ;
Reddy, Dibbanti Harikrishna ;
Thota, Prasad ;
Bansal, Seema ;
Gautam, Bhaswati Sharma ;
Medhi, Bikash .
INDIAN JOURNAL OF PHARMACOLOGY, 2021, 53 (06) :499-510
[3]   Mucormycosis at a tertiary-care center in Mexico. A 35-year retrospective study of 214 cases [J].
Bonifaz, Alexandro ;
Tirado-Sanchez, Andres ;
Hernandez-Medel, Maria L. ;
Araiza, Javier ;
Kassack, Juan J. ;
del Angel-Arenas, Teresa ;
Moises-Hernandez, Jorge F. ;
Paredes-Farrera, Fernando ;
Gomez-Apo, Erick ;
Trevino-Rangel, Rogelio de J. ;
Gonzalez, Gloria M. .
MYCOSES, 2021, 64 (04) :372-380
[4]   Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium [J].
Cornely, Oliver A. ;
Alastruey-Izquierdo, Ana ;
Arenz, Dorothee ;
Chen, Sharon C. A. ;
Dannaoui, Eric ;
Hochhegger, Bruno ;
Hoenigl, Martin ;
Jensen, Henrik E. ;
Lagrou, Katrien ;
Lewis, Russell E. ;
Mellinghoff, Sibylle C. ;
Mer, Mervyn ;
Pana, Zoi D. ;
Seidel, Danila ;
Sheppard, Donald C. ;
Wahba, Roger ;
Akova, Murat ;
Alanio, Alexandre ;
Al-Hatmi, Abdullah M. S. ;
Arikan-Akdagli, Sevtap ;
Badali, Hamid ;
Ben-Ami, Ronen ;
Bonifaz, Alexandro ;
Bretagne, Stephane ;
Castagnola, Elio ;
Chayakulkeeree, Methee ;
Colombo, Arnaldo L. ;
Corzo-Leon, Dora E. ;
Drgona, Lubos ;
Groll, Andreas H. ;
Guinea, Jesus ;
Heussel, Claus-Peter ;
Ibrahim, Ashraf S. ;
Kanj, Souha S. ;
Klimko, Nikolay ;
Lackner, Michaela ;
Lamoth, Frederic ;
Lanternier, Fanny ;
Lass-Floerl, Cornelia ;
Lee, Dong-Gun ;
Lehrnbecher, Thomas ;
Lmimouni, Badre E. ;
Mares, Mihai ;
Maschmeyer, Georg ;
Meis, Jacques F. ;
Meletiadis, Joseph ;
Morrissey, C. Orla ;
Nucci, Marcio ;
Oladele, Rita ;
Pagano, Livio .
LANCET INFECTIOUS DISEASES, 2019, 19 (12) :E405-E421
[5]   Superior Serum Concentrations with Posaconazole Delayed-Release Tablets Compared to Suspension Formulation in Hematological Malignancies [J].
Cumpston, Aaron ;
Caddell, Ryan ;
Shillingburg, Alexandra ;
Lu, Xiaoxiao ;
Wen, Sijin ;
Hamadani, Mehdi ;
Craig, Michael ;
Kanate, Abraham S. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (08) :4424-4428
[6]   Therapeutic Drug Monitoring of Posaconazole: an Update [J].
Dekkers B.G.J. ;
Bakker M. ;
van der Elst K.C.M. ;
Sturkenboom M.G.G. ;
Veringa A. ;
Span L.F.R. ;
Alffenaar J.-W.C. .
Current Fungal Infection Reports, 2016, 10 (2) :51-61
[7]   Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India [J].
Dravid, Ameet ;
Kashiva, Reema ;
Khan, Zafer ;
Bande, Balasaheb ;
Memon, Danish ;
Kodre, Aparna ;
Mane, Milind ;
Pawar, Vishal ;
Patil, Dattatraya ;
Kalyani, Suraj ;
Raut, Prathamesh ;
Bapte, Madhura ;
Saldanha, Charlotte ;
Chandak, Dinesh ;
Patil, Teerthagouda ;
Reddy, Sateesh ;
Bhayani, Krushnadas ;
Suresh, Laxmi ;
Dillibabu, Vishnu ;
Srivastava, Shipra ;
Khandelwal, Shubham ;
More, Sailee ;
Shakeel, Atif ;
Pawar, Mohit ;
Nande, Pranava ;
Harshe, Amol ;
Kadam, Sagar ;
Hallikar, Sudhir ;
Kamal, Nudrat ;
Andrabi, Danish ;
Bodhale, Sachin ;
Raut, Akshay ;
Chandrashekhar, Sangeeta ;
Raman, Chandrashekhar ;
Mahajan, Uma ;
Joshi, Gaurav ;
Mane, Dilip .
MYCOSES, 2022, 65 (05) :526-540
[8]   Mucormycosis-A clinicoepidemiological review of cases over 10 years [J].
Manesh, Abi ;
Rupali, Priscilla ;
Sullivan, Maire O. ;
Mohanraj, Promila ;
Rupa, Vedantam ;
George, Biju ;
Michael, Joy S. .
MYCOSES, 2019, 62 (04) :391-398
[9]   Posaconazole: an emerging therapeutic option for invasive rhino-orbito-cerebral mucormycosis [J].
Manesh, Abi ;
John, Ajoy O. ;
Mathew, Binu ;
Varghese, Lalee ;
Rupa, Vedantam ;
Zachariah, Anand ;
Varghese, George M. .
MYCOSES, 2016, 59 (12) :765-772
[10]   Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India [J].
Muthu, Valliappan ;
Agarwal, Ritesh ;
Rudramurthy, Shivaprakash Mandya ;
Thangaraju, Deepak ;
Shevkani, Manoj Radhakishan ;
Patel, Atul K. ;
Shastri, Prakash Srinivas ;
Tayade, Ashwini ;
Bhandari, Sudhir ;
Gella, Vishwanath ;
Savio, Jayanthi ;
Madan, Surabhi ;
Hallur, Vinay Kumar ;
Maturu, Venkata Nagarjuna ;
Srinivasan, Arjun ;
Sethuraman, Nandini ;
Sibia, Raminder Pal Singh ;
Pujari, Sanjay ;
Mehta, Ravindra ;
Singhal, Tanu ;
Saxena, Puneet ;
Gupta, Varsha ;
Nagvekar, Vasant ;
Prayag, Parikshit ;
Patel, Dharmesh ;
Xess, Immaculata ;
Savaj, Pratik ;
Panda, Naresh ;
Rajagopal, Gayathri Devi ;
Parwani, Riya Sandeep ;
Patel, Kamlesh ;
Deshmukh, Anuradha ;
Vyas, Aruna ;
Sistla, Srinivas Kishore ;
Padaki, Priyadarshini A. ;
Ramar, Dharshni ;
Sarkar, Saurav ;
Rachagulla, Bharani ;
Vallandaramam, Pattabhiraman ;
Premachandran, Krishna Prabha ;
Pawar, Sunil ;
Gugale, Piyush ;
Hosamani, Pradeep ;
Dutt, Sunil Narayan ;
Nair, Satish ;
Kalpakkam, Hariprasad ;
Badhwar, Sanjiv ;
Kompella, Kiran Kumar ;
Singla, Nidhi ;
Navlakhe, Milind .
EMERGING INFECTIOUS DISEASES, 2023, 29 (01) :8-19